Quick Facts

• Targeted Conditions: Fungal infections of the skin, including ringworm.
• Symptom Relief: May help soothe irritation and reduce itching associated with the condition.

White Field is a prescription topical medication used for the management of fungal infections that affect the skin. Its primary use is in providing therapeutic support for conditions such as tinea (ringworm) and athlete's foot.

The medication may assist in alleviating common symptoms associated with these infections, such as irritation, itching, and redness. It is intended to help promote the healing process of the affected skin area.

It is essential to use this product only as directed by a qualified healthcare professional for the specific skin condition being managed.

Regulatory References

1. NIH MedlinePlus on related antifungal therapies

Official Eligibility and Contraindications

White Field is intended for use by adults and older children who do not have documented contraindications. Eligibility for use is strictly defined by regulatory authorities based on age, physiological status, and underlying health conditions.

Population Status	Eligibility Rule
Contraindicated (Must Not Use)	Hypersensitivity to Benzoic Acid, Salicylic Acid, or any component.
	Application to broken, irritated, inflamed, or infected skin in the treatment area.
	Children and teenagers with Influenza or Chicken Pox (due to Reye’s syndrome risk).
	Use during the third trimester of pregnancy.

Age-Group and Condition Restrictions

Age/Condition	Official Regulatory Status
Children Under 2	Contraindicated or Not Recommended.
Children Under 12	Use must be limited and monitored for systemic absorption risk.
Renal or Hepatic Impairment	Requires limited use and monitoring to avoid systemic toxicity.
Pregnancy (1st/2nd Trimesters)	Use only if benefit justifies the potential risk to the fetus.
Breastfeeding Mothers	Restricted use; avoid application to the chest area.

Patients with Diabetes or poor peripheral circulation must use this product only under conditional guidance. The medicine is not to be used over large body surfaces for prolonged periods in any population, as explicitly stated in regulatory documentation.

White Field Interactions with other medicines and products

The interaction profile for White Field (Benzoic Acid and Sodium Salicylate Topical Solution) is primarily based on the systemic absorption potential of its salicylate component, especially when the product is applied over large or damaged areas of skin, or under occlusive dressings.

Regulatory documents emphasize two main categories of documented interactions and necessary constraints:

---

️ Interacting Medicinal Products and Restrictions

Classification	Interacting Substances/Products	Restriction Type
Exposure Risk	Oral Aspirin and other Salicylate-Containing Medications (e.g., topical sports creams)	Avoid co-administration to prevent excessive systemic salicylate exposure.
Pharmacokinetic	Other Highly Protein-Bound Drugs	Salicylates compete for plasma protein binding sites, potentially modifying the action of these drugs or influencing salicylate serum levels.

---

Procedural and Population-Specific Constraints

• Topical Co-Application: Patients are advised to avoid using other topical medications on the treated skin areas unless directed by a healthcare provider.
• Application Method: The use of wet packs or wet-to-dry packs on treated skin should be avoided, as this constraint is documented to reduce the product's effectiveness.
• Vulnerable Populations: Patients with significant renal or hepatic impairment and children under 12 years of age require close monitoring for signs of salicylate toxicity, as reduced clearance can heighten the risk of clinically significant systemic interactions.

The mechanism involves a complementary two-part strategy providing localized pharmacodynamic actions. The primary action is driven by Benzoic Acid, which relies on passive diffusion to cross the fungal cell membrane. Once inside, the H^+ ions are released, overwhelming the organism's Intracellular pH Homeostasis Pathway. This forces the fungus to expend high amounts of energy via the H^+-ATPase (Proton Pump) to expel the protons . This metabolic stress leads to the Cessation of Growth and fungal cell death or growth inhibition.

The second action is performed by Salicylic Acid, which functions as a keratolytic agent. It selectively targets the Intercellular Cement and adhesion structures ( Desmosomes) within the outermost skin layer ( stratum corneum) . The resulting disruption of cell-to-cell binding leads to Accelerated Desquamation (controlled shedding) of the surface layers. This mechanical modification removes the outermost layers of the skin, thereby enhancing the penetration and bioavailability of the Benzoic Acid component to the deeper, colonized layers.

White Field is administered strictly through the topical route and is intended only for external, cutaneous use. The regimen involves applying a thin layer of the solution to the affected skin area, typically adhering to the concentration pattern of Benzoic Acid 6% w/w and Salicylic Acid 3% w/w. The standard application schedule is twice daily, often once in the morning and once in the evening, although initial treatment may sometimes be set at a higher frequency.

For proper administration, the area of skin intended for treatment must be thoroughly cleaned and fully dried before the product is applied. The application amount for adults is generally defined as a thin layer, with guidance suggesting a maximum application amount measured by volumetric metrics such as three fingertip units at a single time for larger affected areas.

The treatment course typically spans several weeks. If no sign of clinical improvement is observed after seven consecutive days of consistent use, the treatment protocol should be reviewed. Restrictions exist regarding use in younger populations: the product is generally not intended for children under 16 years of age unless directed by a physician. Adolescents aged 16 to 18 years may be subject to stricter daily limits on the total amount applied. The solution must never be ingested and contact with open wounds or mucous membranes must be avoided.

Research Evidence / Overview of Studies for White Field

Evidence for Superficial Fungal Skin Infections (Dermatophytosis)

This section summarizes the structure of Randomized Controlled Trials (RCTs) and controlled clinical studies that was studied for the combination of Benzoic Acid and Sodium Salicylate in an external application for use in studies exploring superficial fungal infections. This research was observed in trials exploring how the combination was evaluated in conditions characterized by fluctuating or episodic manifestations of infection, such as ringworm (Tinea Corporis) and jock itch (Tinea Cruris).

The studies explored several key measures. These included assessment of clinical cure (measuring outcomes related to changes in the affected skin areas) and evaluation of mycological cure (clearance of fungus confirmed by laboratory methods). This is a traditional preparation, and research contributes to the broader evidence landscape by showing how it was observed in comparison to compounds developed more recently.

Study Outcomes Examined in Clinical Trials

Clinical trials research examined how frequently subjects achieved mycological clearance, which is an outcome that is confirmed by laboratory testing. They also explored the magnitude of clinical improvement by measuring the size and severity of lesions. The studies applied in studies examining patient-reported experiences by using subjective measures of discomfort. These outcomes related to physical discomfort include changes in itching and redness, which was observed in some studies during the defined study time intervals. The collection of these data helps contextualize how patients reported their experience within the research setting.

What is Still Uncertain About the Research Base

The preparation is considered a traditional agent, and therefore, evidence quality varies across studies when compared to modern antifungal compounds. The certainty remains low for definitive long-term outcomes, as follow-up durations were limited. There are also instances where findings were mixed when comparing this combination agent to newer, single-ingredient topical antifungal drugs.

Furthermore, research has explored the two-part action of the medicine (antifungal and keratolytic), but the specific, isolated contribution of the skin-softening component (from Sodium Salicylate) to the final clearance of the fungus is not fully established by all study designs. The evidence highlights what is known, but also shows that research provides context but not individual predictions; findings describe group patterns, not personal outcomes.

Key Studies & References

1. NIH MedlinePlus Drug Information on Related Antifungal Therapies (Amphotericin B)

Common questions about White Field (FAQ)

Q: What is White Field used for besides the main condition?

The official documentation states the primary approved use is for localized superficial fungal infections. However, one of the active ingredients, the keratolytic component Salicylic Acid, is listed in regulatory documentation for other topical uses, such as helping to manage calluses, corns, and certain warts, depending on the specific formulation and concentration.

Q: How quickly does White Field start working after the first use?

Clinical studies generally assess the overall therapeutic outcome over several weeks, with a formal review for clinical improvement recommended after seven consecutive days of use. The product includes a keratolytic component that acts on the skin surface. This action, related to controlled skin shedding, is observed to occur relatively quickly, though the final therapeutic outcome is measured over weeks.

Q: How long does White Field stay active in the body?

White Field is intended for external use only, with minimal amounts of the salicylate component expected to be absorbed into the bloodstream. Systemically absorbed salicylate is primarily eliminated through urine. Official information indicates that the majority of any systemically absorbed salicylate is cleared from the body within 24 hours, depending on the extent and duration of product use.

Q: Will I feel different right after I start taking White Field?

The regulatory documentation lists common, localized effects that are associated with the application of the solution. These may include sensations like a mild burning or warming, irritation, or redness at the site where the solution was applied. Such effects are generally transient and localized.

Q: Is White Field safe to take long-term?

The regulatory label indicates the product is not intended for continuous, long-term use. The risk of systemic toxicity is noted to increase with prolonged use or when the product is applied over large or broken areas of skin, as described in official documentation.

Q: Is White Field known to interact with birth control pills?

While the topical solution is mainly localized, research on the systemic use of salicylates indicates that their metabolism may be different in individuals who are taking oral contraceptive steroids. The full significance of this finding for the topical solution is not generally described in the product's official documentation.

Q: What is the overall summary of the research evidence for White Field?

The research evidence base is composed of controlled clinical studies and Randomized Controlled Trials (RCTs) that examined measures of clinical cure and laboratory-confirmed clearance of the fungus. Official summaries note that the quality of evidence can vary compared to modern compounds, and that follow-up periods in studies were often limited.

Q: Is White Field considered a controlled substance?

White Field is classified by regulatory bodies as an Over-The-Counter (OTC) dermal therapeutic agent, meaning it is generally available without a prescription. It is generally not listed as a controlled substance by regulatory authorities.

Q: What is the difference between the generic and brand name White Field?

The active ingredients are Benzoic Acid and Sodium Salicylate, and these must be chemically identical in both brand and generic versions, as required by regulatory standards. Any differences are typically found in the inactive ingredients, the solution base, or the packaging.

Q: Can I crush White Field before taking it?

The product is formulated as a liquid Topical Solution intended only for external application to the skin. It is not an oral solid medicine (pill or tablet). Official warnings note that the solution is not to be swallowed or ingested.

Q: Are there specific times of day that White Field is meant to be used?

Official documentation describes the standard application schedule as twice daily. The common practice described in official documents suggests application once in the morning and once in the evening.

Q: Do I need a prescription from a specialist to get White Field?

The product is typically classified as an Over-The-Counter (OTC) medicine for external use. This classification generally means that the solution can be purchased without a prescription from a doctor or specialist.

Q: What happens if I stop taking White Field suddenly?

The documentation does not discuss the effects of sudden cessation. It states that if clinical improvement is not seen after seven consecutive days of use, the treatment protocol is to be formally reviewed.

Q: Is White Field known to affect mood or anxiety levels?

The active ingredients are not typically known to directly impact mood or anxiety when used topically. However, official safety documents list confusion as a possible symptom of rare systemic Salicylate Toxicity, which could affect psychological state.

Q: Are there any specific organs that White Field can affect (like the liver)?

White Field is designed for non-systemic use. Regulatory safety documentation notes that patients with pre-existing severe renal (kidney) or hepatic (liver) impairment require close monitoring. This is because patients with pre-existing impairment in these organs may be at a higher risk of systemic exposure and related toxicity.

Official Storage and Disposal Requirements

Whitfield's Ointment must be stored under specific environmental constraints to maintain its stability, as required by regulatory labeling. The product is to be stored at temperatures not exceeding 30 C or, in some regions, below 25 C. It is mandatory to protect the ointment from light, moisture, and freezing.

Handling and Safety Warnings

Official labeling requires the product to be kept out of the sight and reach of children. A critical handling warning states that fabric such as clothing or bedding in contact with the ointment can become a serious fire hazard and must be kept away from naked flames. The unopened medicine has an official shelf life of 3 years from the date of manufacture. Disposal of expired or unused product must be completed according to local regulations.